Cargando…
Treatment of moderate to severe psoriasis with apremilast over 2 years in the context of long-term treated HIV infection: A case report
Treatment of moderate-to-severe psoriasis in patients with HIV infection is a clinical challenge. We present the case of a patient with a longstanding history of well-controlled HIV. He had failed topical management, and his hypertriglyceridemia made use of acitretin potentially unsafe. He was unabl...
Autores principales: | Zarbafian, Misha, Cote, Benoit, Richer, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503584/ https://www.ncbi.nlm.nih.gov/pubmed/31105941 http://dx.doi.org/10.1177/2050313X19845193 |
Ejemplares similares
-
Dose optimization of brodalumab in moderate-to-severe plaque
psoriasis: A case report
por: Yeung, Jensen, et al.
Publicado: (2020) -
Apremilast monotherapy for palmoplantar pustulosis: Report of three cases
por: Marovt, Maruška, et al.
Publicado: (2021) -
Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis
por: Gisondi, Paolo, et al.
Publicado: (2016) -
Apremilast Pharmacogenomics in Russian Patients with Moderate-to-Severe and Severe Psoriasis
por: Verbenko, Dmitry A., et al.
Publicado: (2020) -
Pediatric psoriasis treated with apremilast
por: Smith, Rebecca L.
Publicado: (2016)